A personally tailored RNA cancer immunotherapy

Modern medicine’s scientific basis necessarily requires its practitioners to diagnose and treat based on a pathology’s similarities rather than its differences. For a diagnosis of liver cancer, for example, the standard of care has been to treat with surgical or chemotherapeutic approaches for that tumor type. When such standard approaches fail, it is reasonable to ascribe the poor outcome to tumor- and/or patient-specific differences. In the last few decades, genetic, biochemical and informatic data have shown the diversity of cancer types suggesting new paths to treat and perhaps one day cure many cancers.